Thee has been a rise in kidney disease due to lifestyle disorders such as diabetes, hypertension and obesity Experts warn ...

Use of sodium-glucose cotransporter-2 inhibitors was linked to significantly reduced risk for adverse kidney, cardiovascular and hepatic outcomes in patients with type 2 diabetes and cirrhosis, ...

Explore emerging strategies to improve clinical outcomes and slow disease progression in patients with diabetic kidney ...

Incidence patterns of STEMI and NSTEMI in type 1 diabetes depend on age, vascular history, and kidney function, a Finnish study finds.

Long-term diabetic dialysis increases mortality risk after AMI. Discover key findings and clinical implications. Read more.

If at any time during the additional 180-day extension, the bid price of the Company's common stock closes at, or above, $1.00 per share for a minimum of ten consecutive business days, the Nasdaq ...